The ACRF Image X Institute is a centre for innovation in radiation therapy and cancer imaging technologies.
We create, share and apply scientific knowledge to improve health by building new technology for cancer imaging and targeted radiation therapy.
We engage with industry, hospitals, international collaborators and universities to forge relationships that help take our projects from lab bench to patient bedside.
Three Postgraduate Research Scholarships – Applications Open
We’re thrilled to be offering three opportunities for postgraduate research across a multitude of disciplines – mathematics, medical physics, engineering and software/algorithm development.
Successful applicants will be offered a $35,000 per annum stipend scholarship to perform research into acquiring CT images of patients as their heart beats, they breathe or during walking. This research has applications in both radiation therapy and radiology, and is a fantastic opportunity to see your research have a positive impact on human health.
Emily Hewson featured in Physics World
PhD Candidate Emily Hewson has been interviewed by new website Physics World about her recently published article assessing multileaf collimator tracking and gating of the radiation therapy beam during treatment.
“Our implementation of KIM to monitor tumour motion, combined with either gating or MLC tracking improves the availability of intrafraction motion adaption for all clinics with standard treatment machines,” says Hewson. “One of the major barriers to implementing real-time adaptive radiotherapy in many countries has been a lack of finances and resources. The adaptive methods we compared could potentially overcome these obstacles and bring intrafraction motion adaptation into standard clinical practice at any cancer treatment facility that treat patients using a modern linear accelerator.”
Dr Paul Liu featured on Phyics World
Paul Liu, has been featured on the prominent Physics news website for his work: MRI-Linac enables simultaneous MLC tracking of two moving targets
Paul has described the use of an MRI-Linac to simultaneously track the motion of two treatment targets. “There are many radiotherapy cases that involve simultaneous treatment of multiple targets,” he said, citing examples such as locally advanced prostate or lung tumours, and oligometastases.
Study identifies missing piece needed for lower-cost, high-quality MRI
David Waddington‘s paper “High-sensitivity in vivo contrast for ultra-low field magnetic resonance imaging using superparamagnetic iron oxide nanoparticles” has been published in Science Advances. The research was completed during David’s Fulbright scholarship, in collaboration with friend of the institute, Zdenka Kuncic (University of Sydney) and Matt Rosen (Massachussetts General Hospital), among others. The paper has been featured in the university’s News and Opinion here, and Medical Xpress here.
Read more news here.
The ACRF Image X Institute is proudly supported by the Australian Cancer Research Foundation.